activity
20172026
most citedMUCE: Bayesian Hierarchical Modeling for the Design and Analysis of Phase 1b Multiple Expansion Cohort Trials

16 citations · 66 across the 14 of their papers we have counts for

collaborators

15 papers

stat.AP2026

Multilevel regression trees with application to wildfires in the American west

John Henry V. Gray, Tianjian Zhou, Benjamin A. Shaby

We propose a Bayesian regression tree model fit within a multilevel structure and apply it to historic wildfire data in the western United States. Sharing of information between re…

stat.ME2023

PAM-HC: A Bayesian Nonparametric Construction of Hybrid Control for Randomized Clinical Trials Using External Data

Dehua Bi, Tianjian Zhou, Wei Zhong +1

It is highly desirable to borrow information from external data to augment a control arm in a randomized clinical trial, especially in settings where the sample size for the contro…

stat.ME2021★ 7 cited

On Bayesian Sequential Clinical Trial Designs

Tianjian Zhou, Yuan Ji

Clinical trials usually involve sequential patient entry. When designing a clinical trial, it is often desirable to include a provision for interim analyses of accumulating data wi…

stat.AP2021★ 10 cited

Tracking the Transmission Dynamics of COVID-19 with a Time-Varying Coefficient State-Space Model

Joshua P. Keller, Tianjian Zhou, Andee Kaplan +2

The spread of COVID-19 has been greatly impacted by regulatory policies and behavior patterns that vary across counties, states, and countries. Population-level dynamics of COVID-1…

stat.ME2021★ 1 cited

Incorporating External Data into the Analysis of Clinical Trials via Bayesian Additive Regression Trees

Tianjian Zhou, Yuan Ji

Most clinical trials involve the comparison of a new treatment to a control arm (e.g., the standard of care) and the estimation of a treatment effect. External data, including hist…

stat.AP2021★ 5 cited

The Ci3+3 Design for Dual-Agent Combination Dose-Finding Clinical Trials

Shijie Yuan, Tianjian Zhou, Yawen Lin +1

We propose a rule-based statistical design for combination dose-finding trials with two agents. The Ci3+3 design is an extension of the i3+3 design with simple decision rules compa…

stat.ME2020

Mixture of Finite Mixtures Model for Basket Trial

Junxian Geng, Tianjian Zhou, Ruitao Lin +1

With the recent paradigm shift from cytotoxic drugs to new generation of target therapy and immuno-oncology therapy during oncology drug developments, patients with various cancer…

stat.ME2020★ 4 cited

Semiparametric Bayesian Inference for the Transmission Dynamics of COVID-19 with a State-Space Model

Tianjian Zhou, Yuan Ji

The outbreak of Coronavirus Disease 2019 (COVID-19) is an ongoing pandemic affecting over 200 countries and regions. Inference about the transmission dynamics of COVID-19 can provi…

stat.ME2020★ 16 cited

MUCE: Bayesian Hierarchical Modeling for the Design and Analysis of Phase 1b Multiple Expansion Cohort Trials

Jiaying Lyu, Tianjian Zhou, Shijie Yuan +2

We propose a multiple cohort expansion (MUCE) approach as a design or analysis method for phase 1b multiple expansion cohort trials, which are novel first-in-human studies conducte…

stat.ME2020★ 1 cited

Statistical Frameworks for Oncology Dose-Finding Designs with Late-Onset Toxicities: A Review

Tianjian Zhou, Yuan Ji

In oncology dose-finding trials, due to staggered enrollment, it might be desirable to make dose-assignment decisions in real-time in the presence of pending toxicity outcomes, for…

stat.AP2019

Posterior Contraction Rate of Sparse Latent Feature Models with Application to Proteomics

Tong Li, Tianjian Zhou, Kam-Wah Tsui +2

The Indian buffet process (IBP) and phylogenetic Indian buffet process (pIBP) can be used as prior models to infer latent features in a data set. The theoretical properties of thes…

stat.AP2019★ 13 cited

PoD-TPI: Probability-of-Decision Toxicity Probability Interval Design to Accelerate Phase I Trials

Tianjian Zhou, Wentian Guo, Yuan Ji

Cohort-based enrollment can slow down dose-finding trials since the outcomes of the previous cohort must be fully evaluated before the next cohort can be enrolled. This results in…

stat.AP2017

Bayesian Nonparametric Models for Biomedical Data Analysis

Tianjian Zhou

In this dissertation, we develop nonparametric Bayesian models for biomedical data analysis. In particular, we focus on inference for tumor heterogeneity and inference for missing…

stat.AP2017★ 1 cited

TreeClone: Reconstruction of Tumor Subclone Phylogeny Based on Mutation Pairs using Next Generation Sequencing Data

Tianjian Zhou, Subhajit Sengupta, Peter Mueller +1

We present TreeClone, a latent feature allocation model to reconstruct tumor subclones subject to phylogenetic evolution that mimics tumor evolution. Similar to most current method…

stat.AP2017★ 8 cited

PairClone: A Bayesian Subclone Caller Based on Mutation Pairs

Tianjian Zhou, Peter Mueller, Subhajit Sengupta +1

Tumor cell populations can be thought of as being composed of homogeneous cell subpopulations, with each subpopulation being characterized by overlapping sets of single nucleotide…